Verisk Analytics, Inc.

Investment Thesis

Rating: BUY | 12-Month Price Target: $245 | Medium-High Conviction

Verisk is a scarce, high-margin insurance-data compounder whose valuation has reset while its underlying subscription engine has reaccelerated. At $206.02, the shares trade at approximately 27.1x the midpoint of 2026 adjusted EPS guidance and 17.1x enterprise value/2026 adjusted EBITDA, a defensible entry point for a business generating 8.2% subscription growth, a 56.7% adjusted EBITDA margin, and durable pricing power embedded in insurer workflows.

The thesis is not that Verisk suddenly becomes a high-teens organic grower. It is that the market is underestimating the compounding value of mid-to-high-single-digit organic growth, 25–75 basis points of annual margin expansion, AI-enhanced price realization, and buyback-supported EPS growth. Q3 OCC revenue growth returned to 7.4%, adjusted EPS increased 14%, and management reaffirmed all 2026 guidance, albeit with an expectation that results land around the midpoint. (finance.yahoo.com)

The principal discount is warranted but excessive: the Delaware Supreme Court has compelled Verisk to continue pursuing the $2.35 billion AccuLynx acquisition, subject to FTC approval and customary conditions. The transaction introduces financing, integration, valuation, contractor-exposure, and governance risks that preclude a full premium multiple until resolved. The court’s October 23, 2026 order affirmed the Chancery Court judgment; it did not eliminate the FTC closing condition or guarantee completion. (courts.delaware.gov)

Key Actionable Takeaways

• Core growth has reaccelerated. Q3 OCC revenue rose 7.4%, versus 5.8% in Q2, with underwriting at 7.7% and claims at 6.7%. Subscription revenue—84% of quarterly revenue—grew 8.2%.
• Guidance was reaffirmed, not raised. Management expects 2026 performance around the midpoint due to lighter weather, elongated enterprise sales cycles, and nonrecurring Q3 transactional overages.
• Capital allocation is aggressive. Verisk funded $1.9 billion of repurchases through the first nine months at an average price of $185.46, below the reference price, but substantially above internally generated nine-month free cash flow of $824 million. (finance.yahoo.com)
• AccuLynx is the swing factor. A close would expand contractor workflow exposure and require substantial financing; failure to secure FTC clearance would preserve balance-sheet flexibility but extend legal and strategic uncertainty.

Valuation Snapshot

The reference price is the intraday market price at approximately 1:53 p.m. Eastern Time on November 5, 2026.

2. Company Deep Dive & Business Model

Business Segmentation

Verisk is now a focused insurance-data, analytics, and workflow company following the divestitures of its energy, financial-services, and marketing-solutions operations.

Revenue composition

Underwriting includes forms, rules and loss costs; catastrophe and risk modeling; risk selection; life-insurance technology; and policy-administration capabilities. Claims includes property estimating, restoration workflows, anti-fraud analytics, casualty compliance, medical-record automation, and international claims technology. (sec.gov)

The revenue model is unusually defensive:

• Hosted subscriptions represented approximately 83% of FY2025 revenue and 84% of Q3 2026 revenue.
• Subscription contracts are generally one to five years, typically prepaid quarterly or annually.
• Transactional revenue—16% of Q3 revenue—is tied to data pulls, claims activity, repair and restoration volumes, and selected professional services.
• Approximately 82% of FY2025 revenue was generated in the United States. (sec.gov)

Customer concentration is manageable. The top 50 customers generated approximately 42% of FY2025 revenue, but no individual customer represented more than approximately 3%. Verisk serves the top 100 U.S. P&C insurers, major reinsurers, self-insured enterprises, third-party administrators, contractors, and government agencies. (sec.gov)

Competitive Moat

1. Contributory-data flywheel

Insurers contribute claims, exposure, pricing, and policy information. Verisk normalizes and returns industry-level intelligence that no single carrier can recreate internally. The moat is not merely dataset size; it is permissioned access, taxonomy, calibration, regulatory acceptance, historical continuity, and integration into production decisions.

Relevant operating evidence from the latest call includes:

• $36 billion of excess-and-surplus premium in the new E&S dataset, up from $18 billion in the prior quarter.
• 21 committed E&S data contributors.
• More than 800 million images in Digital Media Forensics, up from 600 million in March.
• An anti-fraud database containing over 1.9 billion claim records and receiving more than 193,000 new claims daily, according to the FY2025 filing. (sec.gov)

2. Regulatory and workflow entrenchment

Forms, rules, loss costs, statistical-agent reporting, catastrophe models, repair-cost databases, and Medicare compliance are not discretionary dashboards. They sit inside regulated underwriting and claims processes where errors can create reserve, pricing, litigation, and compliance liabilities. Switching costs include model validation, regulatory approval, employee retraining, historical-data continuity, and workflow reconfiguration.

3. Pricing power through continuous content enhancement

Core Lines Reimagine, catastrophe-model updates, new risk datasets, and AI functionality support above-inflation contract pricing. Management indicated it remains on track to deliver 25 new Core Lines modules in 2026. Pricing is increasingly tied to demonstrable product additions rather than contractual inertia, making it more defensible but also requiring sustained development expenditure.

4. AI is more likely to strengthen than disintermediate the moat

Generic models can automate data processing, but they do not independently recreate insurance-specific contributory data, licensed content, claims histories, regulatory forms, or catastrophe science. The latest call supplied direct evidence: a top-five self-insured retailer attempted to use internal data and AI for workers’ compensation fraud detection, found weaker outcomes, and returned to Verisk under a large multiyear agreement.

The risk is not wholesale data obsolescence. It is that AI interfaces commoditize the application layer while customers bargain more aggressively over data usage. Verisk currently includes certain Claude MCP access in Core Lines contracts and monetizes it through renewal pricing, while reserving the right to establish explicit consumption-based charges later.

Management & Governance

Lee Shavel’s strategic simplification has improved business quality: Verisk exited lower-synergy operations and concentrated capital around insurance data and workflow assets. FY2025 revenue landed within final guidance, while adjusted EBITDA and adjusted EPS exceeded the top ends of the final ranges, demonstrating conservative year-end execution. FY2025 adjusted EBITDA reached $1.727 billion and adjusted EPS reached $7.16. (investor.verisk.com)

Capital allocation is more contentious:

• Through September 2026, Verisk repurchased 10.5 million shares for $1.9 billion, averaging $185.46 per share.
• These purchases were economically accretive at the current reference price.
• However, portions of the program were financed with revolver and term-loan borrowings rather than excess free cash flow.
• The accelerated repurchases helped adjusted EPS rise 14% despite adjusted net income increasing only 5.4%.

The AccuLynx litigation is a governance blemish. Verisk attempted to terminate a signed $2.35 billion agreement, lost in Chancery Court, and lost on appeal. Regardless of ultimate economics, the process generated legal costs, financing friction, uncertainty and questions regarding transaction diligence and contractual discipline. The court did not merely award damages; it affirmed an order requiring Verisk to proceed under the agreement and pursue FTC clearance. (courts.delaware.gov)

Sentiment Analysis

Retail sentiment is divided between two simplified narratives:

1. Positive: Verisk is an AI-enabled, recurring-revenue data monopoly with resilient pricing.
2. Negative: It is an overvalued “bond proxy” whose growth is being manufactured through buybacks and whose data moat could be weakened by generative AI.

Institutional positioning is more nuanced. Public 13F aggregation showed 959 reporting managers at June 30, up 11 sequentially, although aggregate institutional shares edged down 0.39%. Short interest stood at approximately 3.4% of float as of October 15, materially lower than its mid-2026 peak but still indicative of active skepticism around valuation and AccuLynx. These ownership datasets are lagged and should not be treated as real-time positioning. (businessquant.com)

3. Market Dynamics & Recent Events

Key News Flow

Q3 2026 operating result

The operating result was stronger than the headline GAAP revenue growth suggested. Divestiture and acquisition effects suppressed reported growth, while OCC growth returned to the company’s medium-term range. The 8.2% subscription result was the quarter’s highest-quality datapoint; the 3.2% transactional result was partly attributable to Life Solutions services and contract overages that management does not expect to repeat in Q4. (finance.yahoo.com)

Guidance Ledger

Management reaffirmed all full-year guidance. No formal Q4, GAAP operating-income, GAAP EPS, free-cash-flow, or segment-level guidance was issued.

(finance.yahoo.com)

AccuLynx

The Delaware Supreme Court’s October 23 order affirmed the August 7 Chancery Court decision. Verisk must proceed in accordance with the merger agreement, including using commercially reasonable efforts to secure antitrust clearance and closing if the applicable conditions are satisfied. The purchase price is $2.35 billion in cash. (courts.delaware.gov)

The deal’s strategic rationale is credible: AccuLynx is an end-to-end contractor workflow platform that could connect Verisk’s Xactware estimating ecosystem with restoration contractors. The financial underwriting remains opaque. Verisk has not disclosed sufficient current revenue, EBITDA, growth, customer-retention, or purchase-multiple data to establish accretion with institutional confidence.

Principal Q&A concerns

Stock Performance

At $206.02, Verisk trades:

• Approximately 9.3% below its 52-week high of $227.16.
• Approximately 32.1% above its 52-week low of $155.94.
• Near 91% of the way from its low to its high.
• Up approximately 4.1% intraday following Q3 results. (investor.verisk.com)

Through November 4, the stock’s one-year total return was approximately 9.2%, versus 13.5% for the S&P 500. Its three- and five-year relative returns also lagged, reflecting multiple compression, business divestitures and transaction uncertainty. (finance.yahoo.com)

Verisk ended 2025 at $223.69 and generated FY2025 adjusted EPS of $7.16, implying approximately 31.2x. The current 27.1x midpoint FY2026 adjusted P/E therefore represents roughly four turns of compression despite stronger Q3 organic growth. (sec.gov)

For context, current trailing P/E multiples are approximately 27.9x for S&P Global, 31.2x for Moody’s, 34.7x for MSCI, and 22.2x for FactSet. These are not perfectly comparable because business mix, accounting and growth differ, but they frame Verisk as neither distressed nor fully valued as a premier data monopoly.

Macro Impact

The Federal Reserve maintained a 3.75%–4.00% target range on October 28 after raising rates in September. September CPI was 3.7% year over year, while core PCE was 3.1%. Higher rates increase Verisk’s interest burden, slow insurance transaction volumes and pressure valuation multiples for long-duration recurring-revenue equities. (federalreserve.gov)

The direct operating effect is less severe than the valuation effect. Insurers continue purchasing regulatory content and risk intelligence through cycles. Inflation can increase insured values, repair costs and demand for current pricing data. Conversely, lighter catastrophe activity reduces claims and restoration transactions, particularly among contractor and adjuster customers.

The P&C industry’s 2026 combined ratio is forecast around 94.0, indicating strong underwriting profitability, but commercial auto and general liability remain structurally challenged. Strong carrier profitability supports technology budgets; softer property pricing and lower claims activity suppress Verisk’s transactional volumes. (iii.org)

4. Financial Statement Analysis (Forensic Detail)

Revenue & Earnings Quality

High-quality recurring base

FY2025 revenue grew 6.6% to $3.073 billion, with underwriting up 7.7% and claims up 4.1%. Adjusted EBITDA increased 9.6% to $1.727 billion, and adjusted EBITDA margin expanded to 56.2% from 54.7%. (sec.gov)

Q3 reinforces the quality of the core:

• Subscription growth was 8.2%.
• Subscription revenue represented 84% of total revenue.
• No individual customer has material concentration.
• Deferred and prepaid subscription economics generally result in cash collection preceding revenue recognition.

GAAP versus adjusted earnings

Q3 GAAP operating income was approximately $365 million, or 45.2% of revenue. Adjusted EBITDA was $459 million, creating an approximately $94 million difference primarily attributable to fixed-asset D&A, intangible amortization, investment adjustments and acquisition-related expenses.

Adjusted EPS of $1.96 was 15% above GAAP EPS of $1.70. The adjustment gap is not alarming, but neither is it economically irrelevant:

• Fixed-asset D&A was $69.5 million in Q3 and $205.7 million through nine months.
• Capital expenditures were $67.2 million in Q3 and $199.3 million through nine months.
• The near equivalence of fixed-asset D&A and capital expenditure indicates that software and technology investment is a recurring economic requirement—not an expense that should be ignored permanently.
• Q3 net income declined because of losses on two cost-basis investments and higher interest expense, even as operations improved. (finance.yahoo.com)

There is no obvious evidence of revenue-recognition aggression. Hosted subscription revenue is recognized ratably over the service period, while transactional revenue is recognized when the service is delivered. The more material forensic issue is reliance on adjusted EBITDA as a performance shorthand despite structurally recurring software capitalization and depreciation. (sec.gov)

Balance Sheet Health & Leverage

Q3 cash was $556.8 million, down from $2.178 billion at year-end 2025, principally reflecting note redemptions and aggressive repurchases. (finance.yahoo.com)

The latest detailed filed debt schedule, at June 30, showed:

The debt is predominantly fixed-rate senior-note financing with long-dated maturities. The near-term exception is the $250 million senior unsecured term loan due in February 2027. Verisk also had approximately $1.245 billion of revolver availability at June 30. (sec.gov)

Management reported Q3 leverage of 2.5x adjusted EBITDA, the midpoint of its 2x–3x target range. Covenant maximum funded leverage is 3.75x, with temporary acquisition-related step-ups available to 4.50x and 4.25x. The covenant cushion is adequate, but a $2.35 billion cash acquisition would consume most practical flexibility unless supported by target EBITDA, new equity, asset sales or rapid deleveraging. (sec.gov)

Cash Flow & Capital Allocation

(finance.yahoo.com)

Q3 FCF fell 40.5% because of semiannual interest payments, higher cash taxes and collection timing. These are partly timing effects, but the full nine-month decline confirms that interest and capital intensity are consuming more cash than the adjusted earnings trend implies.

The dividend is secure. The $2.00 annual dividend represents roughly 26% of midpoint adjusted EPS and approximately $260 million of annual cash outlay at the present share count. Normalized FCF covers that obligation more than four times.

The buyback is less self-funding. Nine-month repurchases exceeded FCF by more than $1 billion. Repurchasing at $185.46 was economically attractive relative to the reference price, but debt-funded repurchases increase financial risk and constrain the ability to absorb AccuLynx without exceeding the preferred leverage range.

5. Valuation & Price Target

Method 1: Forward Adjusted P/E

2027 adjusted EPS estimate: $8.44
Applied multiple: 29.0x
Implied value: $245

The EPS estimate assumes:

• Revenue growth of approximately 7%, anchored to the Q3 subscription trajectory and 2026 guidance midpoint.
• Roughly 50 basis points of adjusted EBITDA margin expansion.
• Higher interest expense partially offsetting operating leverage.
• A 2%–3% lower diluted share count.
• No AccuLynx contribution or dilution in the base estimate.

A 29x multiple is below MSCI’s current trailing multiple, broadly aligned with Moody’s, and modestly above S&P Global. It appropriately reflects Verisk’s superior margins and recurring revenue but lower organic growth and elevated transaction risk.

Method 2: EV/Adjusted EBITDA

2027 adjusted EBITDA estimate: $1.97 billion
Applied EV/EBITDA: 18.0x
Implied enterprise value: $35.5 billion
Less estimated net debt: approximately $3.9 billion
Assumed diluted shares: 129 million
Implied equity value: $245 per share

An 18x multiple is justified by recurring revenue, limited customer concentration, high incremental margins and durable regulatory positioning. It avoids crediting a material AI growth acceleration before enterprise deployments reach production scale.

Method 3: Discounted Cash Flow

Implied value: $238 per share

Core assumptions:

• Starting normalized equity free cash flow of approximately $1.2 billion.
• Five-year FCF growth of 5%–7%.
• Cost of equity of approximately 8%.
• Terminal growth of 3.5%.
• No explicit AccuLynx value creation.
• No structural improvement in working-capital timing.

The DCF is most sensitive to discount rate and terminal growth because Verisk is a long-duration asset. A 100-basis-point increase in the discount rate would produce a material valuation reduction.

Reconciliation

The target does not assign explicit upside from AccuLynx because the target’s current financial profile and financing structure are insufficiently disclosed. Nor does it impose a full deal-break discount because FTC clearance is not assured. The result embeds a continuing transaction-risk haircut to an otherwise premium-quality franchise.

6. Risk, Catalysts, and Scenario Analysis

The Bear Case — Risks

1. AccuLynx destroys capital. Verisk may be legally compelled to close at a stale $2.35 billion valuation despite changes in contractor end markets, financing costs or target performance.
2. FTC remedies impair economics. Clearance could require behavioral restrictions, integration limitations, data-access commitments or divestitures.
3. Debt-funded capital returns prove procyclical. Buybacks reduce the share count but leave less capacity for a forced acquisition or downturn.
4. AI weakens the application layer. Insurers may use internal or third-party AI to replicate workflow functionality while purchasing narrower raw-data feeds.
5. Pricing outruns demonstrated ROI. Current subscription growth is partly price-driven; renewal resistance would expose lower true volume growth.
6. Transactional weakness persists. Lighter weather and softer commercial-property markets could continue to pressure contractors, adjusters and restoration customers.
7. FCF conversion remains below adjusted earnings. Higher interest, taxes and recurring capitalized software expenditure may prevent reported EPS growth from translating into equivalent cash growth.
8. Valuation remains rate-sensitive. A 27x forward multiple is still expensive if the Fed continues tightening and organic growth settles near 5%.

The Bull Case — Catalysts

1. Subscription growth remains at or above 8%.
2. AI functionality drives enterprise licensing rather than remaining bundled into renewals.
3. Synergy Studio installations convert into broader catastrophe-model subscriptions.
4. Forms AI Builder and Mozart move from pilots into Tier-1 enterprise deployments.
5. AI productivity supports the upper end of 25–75 basis points of annual margin expansion.
6. Transactional revenue normalizes with higher catastrophe and repair activity.
7. FTC blocks AccuLynx without material damages, releasing capital for buybacks and organic investment.
8. Alternatively, AccuLynx closes with stronger-than-feared revenue growth and credible integration synergies.
9. Remaining $700 million repurchase authorization is executed below intrinsic value.

Scenario Analysis

Portfolio stance: initiate at 2%–3% of NAV, add below $195 or upon AccuLynx financing clarity, and avoid exceeding 4% before FTC resolution and target-company financial disclosure.

7. Red Team Analysis (Devil’s Advocate)

The BUY thesis may be a sophisticated rationalization for owning a value trap with high-quality optics.

First, Verisk’s growth may be less durable than the subscription headline implies. An 8.2% subscription increase can conceal a business dependent on contract pricing rather than expanding underlying demand. If customer usage, policy counts or seats are growing slowly, Verisk may be harvesting its installed base while presenting the result as innovation-led growth. The call did not disclose retention, net revenue retention, seat growth, new-logo contribution, or price-versus-volume decomposition.

Second, the AI moat can be overstated. Verisk’s data are valuable, but customers may increasingly demand portable data and open interfaces rather than bundled applications. MCP connectors normalize access to Verisk content but may also weaken proprietary front ends by allowing customers to consume the same data through Microsoft, Amazon, Anthropic or in-house agents. Verisk could retain the data relationship while losing application-layer pricing and switching costs.

Third, management’s capital allocation record is now legally compromised. The company signed a $2.35 billion agreement, attempted to terminate it, incurred financing and legal costs, and was ordered to continue performing. A board that misjudged contractual exit rights may also have misjudged purchase price, antitrust exposure or target quality. Shareholders bear the downside whether AccuLynx closes or remains unresolved.

Fourth, the buyback-driven EPS narrative is vulnerable. Adjusted net income increased 5.4% in Q3 while adjusted EPS increased 14%. That is not organic earnings acceleration; it is financial engineering layered onto respectable but ordinary operating growth. The company spent $1.9 billion on buybacks in nine months while generating $824 million of FCF, effectively substituting leverage for organic per-share compounding.

Fifth, adjusted EBITDA materially overstates cash economics. Verisk capitalizes and then depreciates software and technology investment. Fixed-asset D&A and capital expenditures are nearly equivalent, demonstrating that these are ongoing costs of maintaining the platform. A 56% adjusted EBITDA margin can therefore coexist with a materially lower true distributable-cash margin.

Sixth, contractor exposure may be structurally worse than presented. Contractors and adjusters represent approximately 10% of revenue, and management has already identified collection pressure and bankruptcies. AccuLynx would increase exposure to the same ecosystem just as lighter weather and soft property markets strain small businesses. That is adverse selection in capital allocation.

Seventh, the valuation still assumes exceptional durability. At 27x adjusted EPS and 17x EBITDA, the stock is not cheap in absolute terms. If medium-term organic growth is 5%–6%, margin expansion is reinvested, and buybacks slow because of AccuLynx, shareholders could receive high-single-digit EPS growth while the multiple contracts into the low 20s.

Red-team verdict: Verisk becomes a value trap if subscription growth falls below 6%, price realization weakens, FCF conversion remains below 65% of adjusted EBITDA, or AccuLynx requires leverage above the stated target range without immediate accretion. The BUY rating therefore rests on strict operating and capital-allocation tripwires—not blind faith in the historical moat.